Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 4 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 3 completed trials have results

Key Signals

1 recruiting

Enrollment Performance

Analytics

N/A
2(100.0%)
2Total
N/A(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (4)

Showing 4 of 4 trials
NCT06687694Recruiting

Immune Mechanisms of Antipsychotic Treatment Response

Role: collaborator

NCT06091163Not ApplicableCompleted

Ketogenic Diet for Treatment-Resistant Depression: Dietary Interventions for MEntal Health Study (DIME)

Role: collaborator

NCT05412368Completed

Enhancing Referrals to Child and Adolescent Mental Health Services: EnCAMHS

Role: collaborator

NCT02449746Not ApplicableCompleted

Study of Immunotherapy in Autoantibody Positive Psychosis

Role: collaborator

All 4 trials loaded